 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 57 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
ABTC09-04 - A Biomarker and Phase II Study of GDC-0449 in Patients with Recurrent Glioblastoma Multiforme |
 |
San Francisco, CA USA |
 |
04/12/2010 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Houston, TX USA |
 |
03/30/2010 |
 |
 |
 |
Details |
 |
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma |
 |
Charleston, SC USA |
 |
12/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
A PHASE II STUDY OF GLIADEL, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT HIGH GRADE GLIOMA |
 |
Cincinnati, OH USA |
 |
12/02/2009 |
 |
 |
 |
Details |
 |
Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab |
 |
Cincinnati, OH USA |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Cincinnati, OH USA |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA USA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Durham, NC USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
New York, NY USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Tampa, FL USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Omaha, NE USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
 |
Santa Monica, CA USA |
 |
11/29/2008 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH USA |
 |
11/19/2008 |
 |
 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH USA |
 |
11/19/2008 |
 |
 |
 |
Details |
 |
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors |
 |
Cleveland, OH USA |
 |
09/28/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status |
 |
New York, NY USA |
 |
11/08/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
 |
NEW YORK CITY, NY USA |
 |
08/20/2007 |
 |
 |
 |
Details |
 |
Functional image guided removal of brain tumors |
 |
Manhasset, NY USA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis |
 |
Cleveland, OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases |
 |
Chapel Hill, NC USA |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases |
 |
Cleveland, OH USA |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion |
 |
Louisville, KY USA |
 |
05/27/2006 |
 |
 |
 |
 |
 |